Genome Medicine (May 2021)
Genotype–phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders
- Ilaria Mannucci,
- Nghi D. P. Dang,
- Hannes Huber,
- Jaclyn B. Murry,
- Jeff Abramson,
- Thorsten Althoff,
- Siddharth Banka,
- Gareth Baynam,
- David Bearden,
- Ana Beleza-Meireles,
- Paul J. Benke,
- Siren Berland,
- Tatjana Bierhals,
- Frederic Bilan,
- Laurence A. Bindoff,
- Geir Julius Braathen,
- Øyvind L. Busk,
- Jirat Chenbhanich,
- Jonas Denecke,
- Luis F. Escobar,
- Caroline Estes,
- Julie Fleischer,
- Daniel Groepper,
- Charlotte A. Haaxma,
- Maja Hempel,
- Yolanda Holler-Managan,
- Gunnar Houge,
- Adam Jackson,
- Laura Kellogg,
- Boris Keren,
- Catherine Kiraly-Borri,
- Cornelia Kraus,
- Christian Kubisch,
- Gwenael Le Guyader,
- Ulf W. Ljungblad,
- Leslie Manace Brenman,
- Julian A. Martinez-Agosto,
- Matthew Might,
- David T. Miller,
- Kelly Q. Minks,
- Billur Moghaddam,
- Caroline Nava,
- Stanley F. Nelson,
- John M. Parant,
- Trine Prescott,
- Farrah Rajabi,
- Hanitra Randrianaivo,
- Simone F. Reiter,
- Janneke Schuurs-Hoeijmakers,
- Perry B. Shieh,
- Anne Slavotinek,
- Sarah Smithson,
- Alexander P. A. Stegmann,
- Kinga Tomczak,
- Kristian Tveten,
- Jun Wang,
- Jordan H. Whitlock,
- Christiane Zweier,
- Kirsty McWalter,
- Jane Juusola,
- Fabiola Quintero-Rivera,
- Utz Fischer,
- Nan Cher Yeo,
- Hans-Jürgen Kreienkamp,
- Davor Lessel
Affiliations
- Ilaria Mannucci
- Institute of Human Genetics, University Medical Center Hamburg-Eppendorf
- Nghi D. P. Dang
- Department of Pharmacology and Toxicology, University of Alabama
- Hannes Huber
- Department of Biochemistry, Theodor Boveri Institute, Biocenter of the University of Würzburg
- Jaclyn B. Murry
- Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles
- Jeff Abramson
- Department of Physiology, University of California Los Angeles
- Thorsten Althoff
- Department of Physiology, University of California Los Angeles
- Siddharth Banka
- Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester
- Gareth Baynam
- Faculty of Medicine and Health Sciences, University of Western Australia
- David Bearden
- Division of Child Neurology, Department of Neurology, University of Rochester School of Medicine
- Ana Beleza-Meireles
- Clinical Genetics Department, University Hospitals Bristol and Weston
- Paul J. Benke
- Joe DiMaggio Children’s Hospital
- Siren Berland
- Department of Medical Genetics, Haukeland University Hospital
- Tatjana Bierhals
- Institute of Human Genetics, University Medical Center Hamburg-Eppendorf
- Frederic Bilan
- Department of Medical Genetics, Centre Hospitalier Universitaire de Poitiers
- Laurence A. Bindoff
- Department of Clinical Medicine (K1), University of Bergen
- Geir Julius Braathen
- Department of Medical Genetics, Telemark Hospital Trust
- Øyvind L. Busk
- Department of Medical Genetics, Telemark Hospital Trust
- Jirat Chenbhanich
- Division of Medical Genetics, Department of Pediatrics, University of California San Francisco
- Jonas Denecke
- Department of Pediatrics, University Medical Center Eppendorf
- Luis F. Escobar
- Peyton Manning Children’s Hospital, Ascension Health
- Caroline Estes
- Peyton Manning Children’s Hospital, Ascension Health
- Julie Fleischer
- Department of Pediatrics, Southern Illinois University School of Medicine
- Daniel Groepper
- Department of Pediatrics, Southern Illinois University School of Medicine
- Charlotte A. Haaxma
- Department of Pediatric Neurology, Amalia Children’s Hospital and Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen Medical Center
- Maja Hempel
- Institute of Human Genetics, University Medical Center Hamburg-Eppendorf
- Yolanda Holler-Managan
- Division of Neurology, Department of Pediatrics, Ann and Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine
- Gunnar Houge
- Department of Medical Genetics, Haukeland University Hospital
- Adam Jackson
- Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester
- Laura Kellogg
- Kaiser Permanente Sacramento
- Boris Keren
- Département de Génétique, Hôpital La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris
- Catherine Kiraly-Borri
- Genetic Services of Western Australia
- Cornelia Kraus
- Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg
- Christian Kubisch
- Institute of Human Genetics, University Medical Center Hamburg-Eppendorf
- Gwenael Le Guyader
- Department of Medical Genetics, Centre Hospitalier Universitaire de Poitiers
- Ulf W. Ljungblad
- Department of Pediatrics, Vestfold Hospital
- Leslie Manace Brenman
- Department of Genetics, Kaiser Permanente Northern California
- Julian A. Martinez-Agosto
- UCLA Clinical Genomics Center, University of California Los Angeles
- Matthew Might
- Department of Medicine, Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham
- David T. Miller
- Division of Genetics and Genomics, Boston Children’s Hospital
- Kelly Q. Minks
- Division of Child Neurology, Department of Neurology, University of Rochester School of Medicine
- Billur Moghaddam
- Kaiser Permanente Sacramento
- Caroline Nava
- Département de Génétique, Hôpital La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris
- Stanley F. Nelson
- UCLA Clinical Genomics Center, University of California Los Angeles
- John M. Parant
- Department of Pharmacology and Toxicology, University of Alabama
- Trine Prescott
- Department of Medical Genetics, Telemark Hospital Trust
- Farrah Rajabi
- Division of Genetics and Genomics, Boston Children’s Hospital
- Hanitra Randrianaivo
- UF de Génétique Médicale, GHSR, CHU de La Réunion
- Simone F. Reiter
- Department of Medical Genetics, Haukeland University Hospital
- Janneke Schuurs-Hoeijmakers
- Department of Human Genetics, Radboud University Medical Center
- Perry B. Shieh
- Department of Neurology at David Geffen School of Medicine, University of California Los Angeles
- Anne Slavotinek
- Division of Medical Genetics, Department of Pediatrics, University of California San Francisco
- Sarah Smithson
- Clinical Genetics Department, University Hospitals Bristol and Weston
- Alexander P. A. Stegmann
- Department of Human Genetics, Radboud University Medical Center
- Kinga Tomczak
- Department of Neurology, Boston Children’s Hospital
- Kristian Tveten
- Department of Medical Genetics, Telemark Hospital Trust
- Jun Wang
- Department of Pharmacology and Toxicology, University of Alabama
- Jordan H. Whitlock
- Department of Medicine, Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham
- Christiane Zweier
- Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg
- Kirsty McWalter
- GeneDx
- Jane Juusola
- GeneDx
- Fabiola Quintero-Rivera
- Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles
- Utz Fischer
- Department of Biochemistry, Theodor Boveri Institute, Biocenter of the University of Würzburg
- Nan Cher Yeo
- Department of Pharmacology and Toxicology, University of Alabama
- Hans-Jürgen Kreienkamp
- Institute of Human Genetics, University Medical Center Hamburg-Eppendorf
- Davor Lessel
- Institute of Human Genetics, University Medical Center Hamburg-Eppendorf
- DOI
- https://doi.org/10.1186/s13073-021-00900-3
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 19
Abstract
Abstract Background We aimed to define the clinical and variant spectrum and to provide novel molecular insights into the DHX30-associated neurodevelopmental disorder. Methods Clinical and genetic data from affected individuals were collected through Facebook-based family support group, GeneMatcher, and our network of collaborators. We investigated the impact of novel missense variants with respect to ATPase and helicase activity, stress granule (SG) formation, global translation, and their effect on embryonic development in zebrafish. SG formation was additionally analyzed in CRISPR/Cas9-mediated DHX30-deficient HEK293T and zebrafish models, along with in vivo behavioral assays. Results We identified 25 previously unreported individuals, ten of whom carry novel variants, two of which are recurrent, and provide evidence of gonadal mosaicism in one family. All 19 individuals harboring heterozygous missense variants within helicase core motifs (HCMs) have global developmental delay, intellectual disability, severe speech impairment, and gait abnormalities. These variants impair the ATPase and helicase activity of DHX30, trigger SG formation, interfere with global translation, and cause developmental defects in a zebrafish model. Notably, 4 individuals harboring heterozygous variants resulting either in haploinsufficiency or truncated proteins presented with a milder clinical course, similar to an individual harboring a de novo mosaic HCM missense variant. Functionally, we established DHX30 as an ATP-dependent RNA helicase and as an evolutionary conserved factor in SG assembly. Based on the clinical course, the variant location, and type we establish two distinct clinical subtypes. DHX30 loss-of-function variants cause a milder phenotype whereas a severe phenotype is caused by HCM missense variants that, in addition to the loss of ATPase and helicase activity, lead to a detrimental gain-of-function with respect to SG formation. Behavioral characterization of dhx30-deficient zebrafish revealed altered sleep-wake activity and social interaction, partially resembling the human phenotype. Conclusions Our study highlights the usefulness of social media to define novel Mendelian disorders and exemplifies how functional analyses accompanied by clinical and genetic findings can define clinically distinct subtypes for ultra-rare disorders. Such approaches require close interdisciplinary collaboration between families/legal representatives of the affected individuals, clinicians, molecular genetics diagnostic laboratories, and research laboratories.